[1]
R. Hultborn, “Second-Line Endocrine Treatment of Advanced Breast Cancer—A Randomized Cross-Over Study of Medroxy-Progesterone Acetate and Aminoglutethimide”, AO, vol. 35, no. Supp 5, p. 75, Jan. 1996.